Strides Pharma gains on transfer of Bengaluru facility to Syngene

Strides Pharma gains on transfer of Bengaluru facility to Syngene
Strides Pharma gains on transfer of Bengaluru facility to Syngene Stelis and Syngene have executed the final agreements to transfer its Unit 3 multi-modal facility in Bengaluru to Syngene with gross consideration adjusted from Rs 702 crore to Rs 617 crore.

admin